Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2024 Volume 29 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2024 Volume 29 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation

  • Authors:
    • Qi An
    • Jiejing Xia
    • Fanchun Pu
    • Shaobo Shi
  • View Affiliations / Copyright

    Affiliations: Department of Psychiatry, Qingdao Mental Health Center, Qingdao, Shandong 266034, P.R. China
    Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 6
    |
    Published online on: November 15, 2023
       https://doi.org/10.3892/mmr.2023.13129
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lipopolysaccharide‑induced (LPS) neuroinflammation serves an important role in the development of depression. Monocyte chemotactic protein‑1‑induced protein 1 (MCPIP1, also known as ZC3H12A and Regnase‑1) possesses endoribonuclease and deubiquitinase activities. In the present study, the effects of MCPIP1 on LPS‑induced depression were assessed. A mouse model of hippocampal neuroinflammation was established by intraperitoneal injection of LPS. Microglia were treated with LPS, MCPIP1 overexpression vector, MCPIP1 knockdown vector or TLR4 inhibitor. MCPIP1 alleviated LPS‑induced depressive‑like behaviors. MCPIP1 facilitated M2 polarization of microglia. MCPIP1 attenuated the inflammatory response in microglia via inhibition of the TLR4/TNF receptor associated factor 6 (TRAF6)/NF‑κB signaling pathway. The results indicated that MCPIP1 accelerated M2‑polarization of microglia and alleviated depressive‑like behaviors of mice via the inhibition of the TLR4/TRAF6/NF‑κB signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Abdoli N, Salari N, Darvishi N, Jafarpour S, Solaymani M, Mohammadi M and Shohaimi S: The global prevalence of major depressive disorder (MDD) among the elderly: A systematic review and meta-analysis. Neurosci Biobehav Rev. 132:1067–1073. 2022. View Article : Google Scholar : PubMed/NCBI

2 

Rink L, Adams A, Braun C, Bschor T, Kuhr K and Baethge C: Dose-response relationship in selective serotonin and norepinephrine reuptake inhibitors in the treatment of major depressive disorder: A meta-analysis and network meta-analysis of randomized controlled trials. Psychother Psychosom. 91:84–93. 2022. View Article : Google Scholar : PubMed/NCBI

3 

Chin T, Huyghebaert T, Svrcek C and Oluboka O: Individualized antidepressant therapy in patients with major depressive disorder: Novel evidence-informed decision support tool. Can Fam Physician. 68:807–814. 2022. View Article : Google Scholar : PubMed/NCBI

4 

Masand PS: Tolerability and adherence issues in antidepressant therapy. Clin Ther. 25:2289–2304. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Hammen C: Risk factors for depression: An autobiographical review. Ann Rev Clin Psychol. 14:1–28. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Debnath M, Berk M and Maes M: Translational evidence for the inflammatory response system (IRS)/compensatory immune response system (CIRS) and neuroprogression theory of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 111:1103432021. View Article : Google Scholar : PubMed/NCBI

7 

Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR and Lu L: Peripheral cytokine levels and response to antidepressant treatment in depression: A systematic review and meta-analysis. Mol Psychiatry. 25:339–350. 2020. View Article : Google Scholar : PubMed/NCBI

8 

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK and Lanctôt K: A meta-analysis of cytokines in major depression. Biol Psychiatry. 67:446–457. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Miller AH, Maletic V and Raison CL: Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 65:732–741. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Zhang JQ, Wu XH, Feng Y, Xie XF, Fan YH, Yan S, Zhao QY, Peng C and You ZL: Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: Involvement of the neuroinflammatory pathway. Acta Pharmacol Sin. 37:1141–1153. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Zhang JC, Yao W and Hashimoto K: Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol. 14:721–731. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Domingues M, Casaril AM, Birmann PT, Lourenço DA, Vieira B, Begnini K, Lenardão EJ, Collares T, Seixas FK and Savegnago L: Selanylimidazopyridine prevents lipopolysaccharide-induced depressive-like behavior in mice by targeting neurotrophins and inflammatory/oxidative mediators. Front Neurosci. 12:4862018. View Article : Google Scholar : PubMed/NCBI

13 

Yirmiya R, Rimmerman N and Reshef R: Depression as a microglial disease. Trends Neurosci. 38:637–658. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Zhang J, Zheng Y, Luo Y, Du Y, Zhang X and Fu J: Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells. Mol Immunol. 116:29–37. 2019. View Article : Google Scholar : PubMed/NCBI

15 

Kim RE, Shin CY, Han SH and Kwon KJ: Astaxanthin suppresses PM2.5-induced neuroinflammation by regulating Akt phosphorylation in BV-2 microglial cells. Int J Mol Sci. 21:72272020. View Article : Google Scholar : PubMed/NCBI

16 

Wang XL, Chen F, Shi H, Zhang M, Yan L, Pei XY and Peng XD: Oxymatrine inhibits neuroinflammation byRegulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathway. Int Immunopharmacol. 100:1081392021. View Article : Google Scholar : PubMed/NCBI

17 

Wang K, Zhai Q, Wang S, Li Q, Liu J, Meng F, Wang W, Zhang J, Wang D, Zhao D, et al: Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice. Transl Neurosci. 12:469–481. 2021. View Article : Google Scholar : PubMed/NCBI

18 

Xu R, Li Y, Liu Y, Qu J, Cao W, Zhang E, He J and Cai Z: How are MCPIP1 and cytokines mutually regulated in cancer-related immunity? Protein Cell. 11:881–893. 2020. View Article : Google Scholar : PubMed/NCBI

19 

Uehata T and Akira S: mRNA degradation by the endoribonuclease Regnase-1/ZC3H12a/MCPIP-1. Biochim Biophys Acta. 1829:708–713. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Han F, Shen L, Ma H, Wang L, Guo H and Wu X: MCPIP1 alleviates inflammatory response through inducing autophagy in Aspergillus fumigatus keratitis. Int Immunopharmacol. 113:1092792022. View Article : Google Scholar : PubMed/NCBI

21 

Lichawska-Cieslar A, Konieczny P, Szukala W, Declercq W, Fu M and Jura J: Loss of keratinocyte Mcpip1 abruptly activates the IL-23/Th17 and Stat3 pathways in skin inflammation. Biochim Biophys Acta Mol Cell Res. 1868:1188662021. View Article : Google Scholar : PubMed/NCBI

22 

Suk FM, Chang CC, Sun PC, Ke WT, Chung CC, Lee KL, Chan TS and Liang YC: MCPIP1 enhances TNF-α-mediated apoptosis through downregulation of the NF-κB/cFLIP axis. Biology (Basel). 10:6552021.PubMed/NCBI

23 

Wang W, Huang X, Xin HB, Fu M, Xue A and Wu ZH: TRAF family member-associated NF-κB activator (TANK) inhibits genotoxic nuclear factor κB activation by facilitating deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase. J Biol Chem. 290:13372–13385. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Bayne K: Revised guide for the care and use of laboratory animals available. American physiological society. Physiologist. 39:208–211. 1996.PubMed/NCBI

25 

Li W, Ali T, Zheng C, He K, Liu Z, Shah FA, Li N, Yu ZJ and Li S: Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes. Mol Psychiatry. 27:1047–1058. 2022. View Article : Google Scholar : PubMed/NCBI

26 

Song AQ, Gao B, Fan JJ, Zhu YJ, Zhou J, Wang YL, Xu LZ and Wu WN: NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. J Neuroinflammation. 17:1782020. View Article : Google Scholar : PubMed/NCBI

27 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Hauenstein EJ: Depression in adolescence. J Obstet Gynecol Neonatal Nurs. 32:239–248. 2003. View Article : Google Scholar : PubMed/NCBI

29 

Touloumis C: The burden and the challenge of treatment-resistant depression. Psychiatriki. 32:11–14. 2021. View Article : Google Scholar : PubMed/NCBI

30 

Moody J, Yang C, Sedinkin J and Chang Y: Systemic MCPIP1 deficiency in mice impairs lipid homeostasis. Curr Res Pharmacol Drug Discov. 1:1–9. 2020. View Article : Google Scholar : PubMed/NCBI

31 

Tyka K, Jörns A, Dunst A, Tang Y, Bryde TH, Mehmeti I, Walentinsson A, Marselli L, Cnop M, Tyrberg B, et al: MCPIP1 is a novel link between diabetogenic conditions and impaired insulin secretory capacity. Biochim Biophys Acta Mol Basis Dis. 1867:1661992021. View Article : Google Scholar : PubMed/NCBI

32 

Bugara B, Konieczny P, Wolnicka-Glubisz A, Eckhart L, Fischer H, Skalniak L, Borowczyk-Michalowska J, Drukala J and Jura J: MCPIP1 contributes to the inflammatory response of UVB-treated keratinocytes. J Dermatol Sci. 87:10–18. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Krajewski PK, Szukała W, Lichawska-Cieślar A, Matusiak Ł, Jura J and Szepietowski JC: MCPIP1/Regnase-1 expression in keratinocytes of patients with hidradenitis suppurativa: Preliminary results. Int J Mol Sci. 22:72412021. View Article : Google Scholar : PubMed/NCBI

34 

Kotlinowski J, Hutsch T, Czyzynska-Cichon I, Wadowska M, Pydyn N, Jasztal A, Kij A, Dobosz E, Lech M, Miekus K, et al: Deletion of Mcpip1 in Mcpip1(fl/fl)Alb(Cre) mice recapitulates the phenotype of human primary biliary cholangitis. Biochim Biophys Acta Mol Basis Dis. 1867:1660862021. View Article : Google Scholar : PubMed/NCBI

35 

Monin L, Gudjonsson JE, Childs EE, Amatya N, Xing X, Verma AH, Coleman BM, Garg AV, Killeen M, Mathers A, et al: MCPIP1/Regnase-1 restricts IL-17A- and IL-17C-dependent skin inflammation. J Immunol. 198:767–775. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Gorka J, Marona P, Kwapisz O, Rys J, Jura J and Miekus K: The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors. Eur J Pharmacol. 888:1735912020. View Article : Google Scholar : PubMed/NCBI

37 

Huang S, Miao R, Zhou Z, Wang T, Liu J, Liu G, Chen YE, Xin HB, Zhang J and Fu M: MCPIP1 negatively regulates toll-like receptor 4 signaling and protects mice from LPS-induced septic shock. Cell Signal. 25:1228–1234. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Han S, Li Z, Ji P, Jia Y, Bai X, Cai W, Li X, Yang C, Yang Y, Yang K, et al: MCPIP1 alleviated lipopolysaccharide-induced liver injury by regulating SIRT1 via modulation of microRNA-9. J Cell Physiol. 234:22450–22462. 2019. View Article : Google Scholar : PubMed/NCBI

39 

Zhang Y, Huang T, Jiang L, Gao J, Yu D, Ge Y and Lin S: MCP-induced protein 1 attenuates sepsis-induced acute lung injury by modulating macrophage polarization via the JNK/c-Myc pathway. Int Immunopharmacol. 75:162019. View Article : Google Scholar

40 

Liang J, Wang J, Saad Y, Warble L, Becerra E and Kolattukudy PE: Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines. J Neuroinflammation. 8:1822011. View Article : Google Scholar : PubMed/NCBI

41 

Arioz BI, Tastan B, Tarakcioglu E, Tufekci KU, Olcum M, Ersoy N, Bagriyanik A, Genc K and Genc S: Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1/Nrf2 pathway. Front Immunol. 10:15112019. View Article : Google Scholar : PubMed/NCBI

42 

Slavich GM and Sacher J: Stress, sex hormones, inflammation, and major depressive disorder: Extending social signal transduction theory of depression to account for sex differences in mood disorders. Psychopharmacology (Berl). 236:3063–3079. 2019. View Article : Google Scholar : PubMed/NCBI

43 

Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C and Camus V: Neuroinflammation and depression: A review. Eur J Neurosci. 53:151–171. 2021. View Article : Google Scholar : PubMed/NCBI

44 

Carlessi AS, Borba LA, Zugno AI, Quevedo J and Réus GZ: Gut microbiota-brain axis in depression: The role of neuroinflammation. Eur J Neurosci. 53:222–235. 2021. View Article : Google Scholar : PubMed/NCBI

45 

Ali T, Rahman SU, Hao Q, Li W, Liu Z, Shah FA, Murtaza I, Zhang Z, Yang X, Liu G and Li S: Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation. J Pineal Res. 69:e126672020. View Article : Google Scholar : PubMed/NCBI

46 

Li W, Ali T, He K, Liu Z, Shah FA, Ren Q, Liu Y, Jiang A and Li S: Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression. Brain Behav Immun. 92:10–24. 2021. View Article : Google Scholar : PubMed/NCBI

47 

Wang L, Li M, Zhu C, Qin A, Wang J and Wei X: The protective effect of Palmatine on depressive like behavior by modulating microglia polarization in LPS-induced mice. Neurochem Res. 47:3178–3191. 2022. View Article : Google Scholar : PubMed/NCBI

48 

Xu X, Piao HN, Aosai F, Zeng XY, Cheng JH, Cui YX, Li J, Ma J, Piao HR, Jin X and Piao LX: Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB pathways. Br J Pharmacol. 177:5224–5245. 2020. View Article : Google Scholar : PubMed/NCBI

49 

Guo LT, Wang SQ, Su J, Xu LX, Ji ZY, Zhang RY, Zhao QW, Ma ZQ, Deng XY and Ma SP: Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway. J Neuroinflammation. 16:952019. View Article : Google Scholar : PubMed/NCBI

50 

Chen S, Lyu C, Zhou J, Huang S, Zhang Y, Liu G, Liu K, Chen D, Hu Y, Zhou L and Gu Y: TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microglia. Neurosci Lett. 686:33–40. 2018. View Article : Google Scholar : PubMed/NCBI

51 

El-Shamarka ME, Eliwa HA and Ahmed MAE: Inhibition of boldenone-induced aggression in rats by curcumin: Targeting TLR4/MyD88/TRAF-6/NF-κB pathway. 51. El-Shamarka ME, Eliwa HA and Ahmed MAE: Inhibition of boldenone-induced aggression in rats by curcumin: Targeting TLR4/MyD88/TRAF-6/NF-κB pathway. J Biochem Mol Toxicol. 36:e229362022. View Article : Google Scholar : PubMed/NCBI

52 

Ran Y, Qie S, Gao F, Qie S, Gao F, Ding Z, Yang S, Tian G, Liu Z and Xi J: Baicalein ameliorates ischemic brain damage through suppressing proinflammatory microglia polarization via inhibiting the TLR4/NF-κB and STAT1 pathway. Brain Res. 1770:1476262021. View Article : Google Scholar : PubMed/NCBI

53 

Jin X, Liu MY, Zhang DF, Zhong X, Du K, Qian P, Yao WF, Gao H and Wei MJ: Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway. CNS Neurosci Ther. 25:575–590. 2019. View Article : Google Scholar : PubMed/NCBI

54 

Muhammad T, Ikram M, Ullah R, Rehman SU and Kim MO: Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling. Nutrients. 11:6482019. View Article : Google Scholar : PubMed/NCBI

55 

Cui Y, Wang Y, Zhao D, Feng X, Zhang L and Liu C: Loganin prevents BV-2 microglia cells from Aβ(1–42)-induced inflammation via regulating TLR4/TRAF6/NF-κB axis. Cell Biol Int. 42:1632–1642. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
An Q, Xia J, Pu F and Shi S: MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation. Mol Med Rep 29: 6, 2024.
APA
An, Q., Xia, J., Pu, F., & Shi, S. (2024). MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation. Molecular Medicine Reports, 29, 6. https://doi.org/10.3892/mmr.2023.13129
MLA
An, Q., Xia, J., Pu, F., Shi, S."MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation". Molecular Medicine Reports 29.1 (2024): 6.
Chicago
An, Q., Xia, J., Pu, F., Shi, S."MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation". Molecular Medicine Reports 29, no. 1 (2024): 6. https://doi.org/10.3892/mmr.2023.13129
Copy and paste a formatted citation
x
Spandidos Publications style
An Q, Xia J, Pu F and Shi S: MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation. Mol Med Rep 29: 6, 2024.
APA
An, Q., Xia, J., Pu, F., & Shi, S. (2024). MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation. Molecular Medicine Reports, 29, 6. https://doi.org/10.3892/mmr.2023.13129
MLA
An, Q., Xia, J., Pu, F., Shi, S."MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation". Molecular Medicine Reports 29.1 (2024): 6.
Chicago
An, Q., Xia, J., Pu, F., Shi, S."MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation". Molecular Medicine Reports 29, no. 1 (2024): 6. https://doi.org/10.3892/mmr.2023.13129
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team